TheraRadar
← Back
Data updated: Mar 29, 2026

POINTVIEW HLDINGS

Pharmaceuticals
Generics

POINTVIEW HLDINGS is a generic drug manufacturer with 4 FDA-approved products.

2015
Since
4
Drugs
-
Trials
58
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

PREDNISONE 2025-10-01
MEMANTINE HYDROCHLORIDE 2025-08-28
MEMANTINE HYDROCHLORIDE 2025-04-25
Labeling
MEMANTINE HYDROCHLORIDE 2025-04-18
Manufacturing (CMC)
METHOCARBAMOL 2025-04-08
Labeling
CARISOPRODOL 2024-11-14
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...